Lumiera Health (TSXV:NHP.H) Debt-to-Asset : 5.22 (As of Aug. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Lumiera Health Debt-to-Asset?

Lumiera Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was C$0.93 Mil. Lumiera Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was C$0.39 Mil. Lumiera Health's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Aug. 2023 was C$0.25 Mil. Lumiera Health's debt to asset for the quarter that ended in Aug. 2023 was 5.22.

Lumiera Health Debt-to-Asset Historical Data

The historical data trend for Lumiera Health's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumiera Health Debt-to-Asset Chart

Lumiera Health Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Nov18

Nov19

Nov20

Nov21

Nov22

Debt-to-Asset

Get a 7-Day Free Trial

0.17

0.46

0.24

0.52

6.82

Lumiera Health Quarterly Data
	Sep18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Debt-to-Asset	Get a 7-Day Free Trial															1.21	6.82	4.58	5.41	5.22

Competitive Comparison of Lumiera Health's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Lumiera Health's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumiera Health's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lumiera Health's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Lumiera Health's Debt-to-Asset falls into.

Lumiera Health Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Lumiera Health's Debt-to-Asset for the fiscal year that ended in Nov. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.413	+	0.483)	/	0.278
	=	6.82

Lumiera Health's Debt-to-Asset for the quarter that ended in Aug. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.93	+	0.39)	/	0.253
	=	5.22

Lumiera Health (TSXV:NHP.H) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Lumiera Health Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Lumiera Health's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumiera Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lumiera Health Inc (TSXV:NHP.H) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

4500 Kimber, Suite 26, Saint-Hubert, QC, CAN, J3Y 8K5

Website

https://www.lumiera.ca

Lumiera Health Inc is a natural health products company. The company is developing products focusing on the endocannabinoid system and providing treatments for chronic pain and inflammation.

Lumiera Health Headlines

No Headlines